SPAC Update – June 29

– LGST announced a business combination with Tevogen Bio
– GFX stockholders approved deadline extension to Aug 24 2023, 3.1 million shares (73.8%) redeemed, 1.1 million shares remain
– LFAC stockholders approved deadline extension to Nov 19 2023, 5.6 million shares (49.6%) redeemed, 5.7 million shares remain, NAV $10.64
– GLTA filed DEF14a to extend deadline to Jan 13 2024, vote July 12
– APAC filed PRE14a to extend deadline to Jan 20 2024, vote in July, NAV $10.89
– RRAC filed PRE14a to extend deadline to Aug 9 2024
– XPAX filed PRE14a to extend deadline to Aug 3 2024, vote in July
– DTOC filed S-4/a for American Oncology Network deal, NAV $10.39
– ACAX filed S-4/a for HWH International deal
– HCMA extended deadline to July 25 2023, added $143k to trust account
– WTMA extended deadline to July 30 2023, added $125k to trust account
– VSAC to extend deadline to Aug 3 2023, to add $73k to trust account
– PMGM deal vote adjourned to June 30
– GOGN deal vote
– ERES deal vote
– QOMO extension vote
– ROSE extension vote
– FICV extension vote
– VBOC redemption